Search - tctmd.com

Displaying 41 - 60 of 173

Sort: Relevancy | Date

Presentation TCT 2022

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

Presenter: Mina Shafiei

September 19, 2022

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Todd Neale

March 01, 2022

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News EuroPCR 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

Caitlin E. Cox

May 21, 2021

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

News Daily News

Primary PCI After TAVI: New Real-world Insights

Caitlin E. Cox

April 27, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Conference News CRT 2021

LRT Trial Data Bolster Support for TAVI in Bicuspid Valves

L.A. McKeown

March 11, 2021

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Caitlin E. Cox

October 29, 2020

Presentation TCT 2020

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Hashrul Rashid

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Opinion CV Team Dispatch

October 2020 News Roundup

L.A. McKeown

October 01, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

Advertisement

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Primary PCI After TAVI: New Real-world Insights

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

LRT Trial Data Bolster Support for TAVI in Bicuspid Valves

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

October 2020 News Roundup

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content